Short answer
LifeMD, Inc. (LFMD) filed its Q3 2025 10-Q quarterly report on Nov 17, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $59M (up 10.6% year over year) with net income of −$5M.
Q3 2025 key financials · XBRL
- Revenue
- $59M
- +10.6% YoY · −5.1% QoQ
- Net income
- −$5M
- +4.1% YoY · −137.1% QoQ
- Operating margin
- -5.2%
- Gross margin
- 87.5%
Source: XBRL data from the LifeMD, Inc. (LFMD) Q3 2025 10-Q on SEC EDGAR. USD.
LifeMD, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new risk factors added this quarter; risks same as 2024 10-K
- Most material risk carried forward: significant regulatory scrutiny from SEC and state health authorities
- Operational risk: dependence on timely adoption of telehealth technology affecting near-term patient growth
- Financial risk: liquidity constrained with current cash $8M, raising concerns about meeting near-term obligations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeMD, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.